The authors also report improvements in the intestinal mucosal barrier, decreased levels of bacterial lipopolysaccharide (LPS), and increased GLP-1 in the portal vein, suggesting a complex and multifaceted mode of action of CGA in alleviating liver steatosis and regulating the gut/liver axis [67,79]. The gene discussed is GCG; the disease is Hepatic steatosis.